Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells.
Zahra JabbarpourSajjad AghayanBabak ArjmandKhadijeh FallahzadehSepideh Alavi-MoghadamBagher LarijaniHamid Reza AghayanPublished in: Stem cell research & therapy (2022)
Our results demonstrated that HS was a better serum alternative than FBS for in vitro expansion of FPMSCs. Compared with FBS, HS increased FPMSCs' proliferation rate and decreased their senescence. In conclusion, HS can effectively replace FBS for clinical-grade FPMSCs manufacturing.